ストックスクリーナーアプリを入手
1.37
0.00%
0.00
前日終値:
$1.37
開ける：
$1.41
24時間の取引高:
22,170
Relative Volume:
0.13
時価総額：
$6.13M
収益：
-
当期純損益:
$-8.22M
株価収益率:
-0.0501
EPS:
-27.3467
ネットキャッシュフロー:
$-8.01M
1週間 パフォーマンス:
-4.20%
1か月 パフォーマンス:
+3.01%
6か月 パフォーマンス:
-41.70%
1年 パフォーマンス:
-90.94%
1日の値動き範囲:
$1.34
$1.41
1週間の範囲:
$1.1701
$1.52
52週間の値動き範囲:
$1.1701
$15.12
Enveric Biosciences Inc Stock (ENVB) Company Profile
名前
Enveric Biosciences Inc
セクター
電話
(617) 444-8400
住所
245 FIRST STREET RIVERVIEW II 18TH FLOOR, CAMBRIDGE
Compare ENVB vs VRTX, REGN, ARGX, MRNA, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ENVB
Enveric Biosciences Inc
|
1.37 | 6.22M | 0 | -8.22M | -8.01M | -27.35 |
VRTX
Vertex Pharmaceuticals Inc
|
541.69 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
794.19 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,023.21 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
137.99 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
207.88 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Enveric Biosciences Inc (ENVB) 最新ニュース
ARMISTICE CAPITAL, LLC Acquires Stake in Enveric Biosciences Inc (ENVB) - GuruFocus
Enveric (ENVB) Snapshot: Slides 0.74% to $1.34 in the Latest Reading; Technical View: Support at $1.27 and Resistance at $1.41 Frame the Range in Latest TradingFundamental Weighted - vinanet.vn
Enveric (ENVB) Daily Review: Moves 8.78% Lower to $1.35 for the Current Session; Price-Level Context: the Supplied Trading Band Runs From $1.28 to $1.42 in Latest TradingVanna Flow - vinanet.vn
Enveric Biosciences (ENVB) Q2 Results Highlight Challenges Amid Low Valuation Signals - GuruFocus
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026 - BioSpace
Enveric Biosciences Announces Withdrawal Of Petition Against Its Patent — ENVB Stock Rises - Stocktwits
Form 8K Enveric Biosciences Inc For: 14 August By Investing.com - Investing.com Nigeria
Enveric Biosciences reports $3.0M net loss, $8.3M cash on hand for Q2 2026 - TradingView
Enveric Biosciences (ENVB) posts H1 2026 loss but raises $8.3M cash - Stock Titan
Enveric Biosciences Posts $3.0 Million Second-Quarter Net Loss - Quiver Quantitative
Enveric Biosciences (NASDAQ: ENVB) deepens Q2 loss while pushing EB-003 toward trials - Stock Titan
Enveric Biosciences (ENVB) holders Lind entities report 1.3–1.4% warrant-based stake - Stock Titan
Armistice Capital (ENVB) discloses 405,092-share position in Enveric Biosciences - Stock Titan
Enveric Biosciences (ENVB) investors disclose 2.93% stake via 111,145-share warrants - Stock Titan
FDA Fast-Tracks Psychedelic Research After Trump’s Executive Order — CMPS, HELP Stocks Gain - Stocktwits
Enveric Biosciences Adds Another Data Point to Its Case That EB-003 Won’t Get You High - microdose.buzz
ENVB Q4 2024 Earnings: Per-Share Loss of -57.6 Overshoots Consensus by 1,946%Management Guidance Update - Vinanet
Enveric Biosciences Inc (NASDAQ: ENVB) Share Price, ENVB Stock News, ENVB Share Price & Updates - Kalkine
Enveric Biosciences Says New Preclinical Data Confirms Non-Hallucinogenic Profile For Lead Psychiatric Ca - Benzinga
Enveric reports preclinical data on EB-003 drug candidate By Investing.com - Investing.com Canada
Enveric Biosciences Reports New Preclinical Data Supporting the Non-Hallucinogenic Profile of Lead Candidate EB-003 - Yahoo! Finance Canada
Enveric Biosciences (ENVB) Rallies 8.4% to $1.57 — Key Levels to WatchStock Analysis - dars.gov.et
Enveric Biosciences Welcomes Final FDA Guidance for Psychedelic Drug Development - Investing News Network
Enveric Biosciences Inc (ENVB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
ENVB|Enveric Biosciences Inc|Price:1.137|Chg%:-0.203 - TradingKey
TradingKey - TradingKey
ENVB|Enveric Biosciences Inc|Price:1.290|Chg%:-0.030 - TradingKey
Enveric Biosciences Inc (ENVB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Enveric Biosciences (ENVB) Slides to $1.29, Testing Key Support at $1.23Positive Gamma - vinanet.vn
Enveric Biosciences Inc (ENVB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Enveric Biosciences Shares Edge Lower as Support Level ApproachesBeta Neutral Pair - dars.gov.et
ENVB Q4 2024 Earnings: Massive EPS Miss Highlights Pre-Revenue Biotech ChallengesEstimate Revision Count - vinanet.vn
Enveric Biosciences (ENVB) Retreats 4.5% as Selling Pressure Intensifies Near Key SupportGrowth Stock Picks - dars.gov.et
ENVB Technical Analysis | Trend, Signals & Chart Patterns - ChartMill
Stock market today: Perfect Moment posted rise of 89.86% whereas Enveric Biosciences saw fall of 45.64% in early trading - Business Upturn
Enveric Biosciences Inc (ENVB:UW): Stock Price, Quote and News - BNN Bloomberg
Price to sales forward of Enveric Biosciences, Inc. – NASDAQ:ENVB - TradingView
Price to sales forward of Enveric Biosciences, Inc. – BOATS:ENVB - TradingView
MSN Money - MSN
Enterprise value to EBITDA forward of Enveric Biosciences, Inc. – NASDAQ:ENVB - TradingView
Price to book forward of Enveric Biosciences, Inc. – NASDAQ:ENVB - TradingView
Enveric Biosciences (ENVB) Slips 5.6%: Testing Key Support as Biotech Sentiment WanesJelly Roll Trade - dars.gov.et
Enveric Biosciences (ENVB) Rebounds Slightly, Testing Key Resistance Near $1.50Earnings Miss Risk - dars.gov.et
Enterprise value to EBIT forward of Enveric Biosciences, Inc. – NASDAQ:ENVB - TradingView
Price to earnings forward of Enveric Biosciences, Inc. – NASDAQ:ENVB - TradingView
ENVB Q4 2024 Earnings: Significant Earnings Miss Amid Pre-Revenue StageEarnings Manipulation Risk - dars.gov.et
ENVB Q4 2024 Earnings: Significant EPS Miss Highlights Ongoing R&D Investment Amid Pre-Revenue StageEarnings Quality Score - dars.gov.et
Enveric Biosciences to Participate in B. Riley's Mind, Muscle & Vision Summit - GuruFocus
Enveric Biosciences Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit - Business Wire
ENVBEnveric Biosciences Inc Earnings - Finviz
Enveric Biosciences Company Profile & Introduction - Moomoo
Enveric Biosciences Inc (ENVB) 財務データ
収益
当期純利益
現金流量
EPS
8.37%
0.23%
大文字化:
|
ボリューム (24 時間):